This study investigated the differences in clinical outcomes between patients with bifurcation lesions (BL) treated with a biolimus-eluting stent (BES) with a biodegradable polymer, and a sirolimus-eluting stent (SES) with a durable polymer.
Differences in the approval process for interventional devices in Europe and USA: IN MEDIO STAT VIRTUS / Di Mario C.; Bailey S.; James S.; Serruys P.; Krucoff M.W.. - In: EUROINTERVENTION. - ISSN 1774-024X. - ELETTRONICO. - 6:(2011), pp. 913-917. [10.4244/EIJV6I8A159]
Differences in the approval process for interventional devices in Europe and USA: IN MEDIO STAT VIRTUS
Di Mario C.;
2011
Abstract
This study investigated the differences in clinical outcomes between patients with bifurcation lesions (BL) treated with a biolimus-eluting stent (BES) with a biodegradable polymer, and a sirolimus-eluting stent (SES) with a durable polymer.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Garg S EuroIntervention 2011 PAG. 928-935.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
1.14 MB
Formato
Adobe PDF
|
1.14 MB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
